CAM
BNTX icon

Cormorant Asset Management’s BioNTech BNTX Stock Holding History

Cormorant Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100,000
Closed -$10.9M – 108
2021
Q1 		$10.9M Sell
100,000
-175,000
-64% -$18.6M 0.24% 71
2020
Q4 		$22.4M Sell
275,000
-50,000
-15% -$4.91M 0.53% 44
2020
Q3 		$22.4M Buy
325,000
+150,000
+86% +$10.8M 0.86% 36
2020
Q2 		$11.7M Buy
+175,000
New +$8.74M 0.45% 54

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Cormorant Asset Management's BNTX Position: Q2 2021 in Review

Cormorant Asset Management sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 100,000 shares — an estimated $10.9M sold.

Cormorant Asset Management first reported a position in BNTX in Q2 2020 and held it in 4 quarters. The position peaked at $22.4M in Q4 2020. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

  • Cormorant Asset Management reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
  • Cormorant Asset Management sold 100,000 BioNTech shares in Q2 2021, an estimated $10.9M.
  • Cormorant Asset Management first reported a position in BioNTech in Q2 2020 and held it in 4 quarters.
  • Cormorant Asset Management's BioNTech position peaked at $22.4M in Q4 2020.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Cormorant Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.